Veterinary Implants Devices Market

The veterinary implant devices market is projected to reach USD 0.98 billion by 2031 from USD 0.74 billion in 2026, growing at a CAGR of 5.7% during the forecast period. The market is expanding as the demand for advanced animal healthcare increases across companion animals, livestock, research, and specialty veterinary care. Rising pet ownership, greater expenditure on veterinary treatment, and the expansion of specialty hospitals are supporting adoption of orthopedic implants, cardiovascular and interventional devices, urinary implants, therapeutic implants, and implantable monitoring systems. Growing use of fracture fixation, tibial plateau leveling osteotomy (TPLO), tibial tuberosity advancement (TTA), joint replacement, cardiac interventions, urinary stents, and reproductive implants is broadening the application scope of veterinary implants. Technology is also transforming veterinary implant design and applications. Manufacturers are developing anatomically contoured and patient-specific implants, bioabsorbable materials, minimally invasive devices, and implantable sensors for continuous physiological monitoring. Three-dimensional (3D) printing and digital surgical planning are enabling customized implants and surgical guides for complex anatomical defects, while wireless telemetry and intraruminal sensing technologies are expanding monitoring applications in clinical, livestock, and research settings. Overall, increasing adoption of advanced veterinary procedures, specialty care, and connected implant technologies is expected to support sustained growth of the veterinary implant devices market.

The prominent players in the veterinary implant devices market are Merck & Co., Inc. (US), Elanco (US), Johnson & Johnson (DePuy Synthes) (US), Zoetis Inc. (US), and Virbac (France). These players have a comprehensive product portfolio and a strong geographic presence globally. They focus on developing innovative products and technologies, expanding label indications to cater to the needs of veterinarians, livestock producers, and pet owners. For instance, in May 2026, Zoetis Inc. received an expanded US label for Synovex One Grower, a cattle growth-promoting implant, for growing beef steers and heifers maintained in dry lots or on pasture with insufficient forage. The expanded indication broadens the product’s approved use across cattle production systems and strengthens Zoetis’ livestock implant portfolio.

To know about the assumptions considered for the study download the pdf brochure

MERCK & CO., INC. (US)

Merck & Co., Inc., through Merck Animal Health, is a prominent player in the veterinary implant devices market, supported by its livestock implant and animal identification and monitoring portfolio. The company offers Revalor implants for beef cattle growth performance and Biomark identification and monitoring technologies, including injectable passive integrated transponder (PIT) tags and readers. Merck Animal Health’s broad livestock portfolio, established global distribution network, and presence across cattle health and production applications strengthened its position in the market.

ELANCO (US)

Elanco Animal Health Incorporated is a global animal-health company that manufactures veterinary implants primarily for livestock production applications. The company’s portfolio includes Component, Compudose, and Encore cattle implants, which are designed to improve growth rate and feed efficiency in beef cattle. These products support cattle production by providing controlled-release active ingredients through implantable systems. The company focuses on livestock health and production technologies through product development, manufacturing capabilities, and a broad commercial and distribution network. Its expertise in cattle production, established animal-health portfolio, and experience with implant-based growth-promotant products support its presence in the veterinary implant devices market.

Market Ranking

The global veterinary implant devices market is moderately fragmented, with Merck & Co., Inc., Elanco Animal Health, and Johnson & Johnson (DePuy Synthes Vet) representing key companies across livestock and orthopedic implant applications. Merck Animal Health has a broad livestock implant portfolio built around the REVALOR cattle implant line, complemented by Biomark identification and monitoring technologies. Its combination of production-performance implants, animal identification, monitoring capabilities, and established livestock-health infrastructure extends its presence across multiple veterinary implant applications. Elanco Animal Health competes primarily through its Component, Compudose, and Encore cattle implant portfolio, supported by its large farm-animal customer base, established animal-health infrastructure, and global commercial network. Its veterinary implant exposure is concentrated primarily in livestock growth-performance applications.

Johnson & Johnson (DePuy Synthes Vet) has a strong position in veterinary orthopedic implants through products including TPLO systems, fracture fixation plates and screws, and arthrodesis systems. Its established orthopedic engineering and manufacturing capabilities, combined with procedure-specific veterinary implant systems, support its presence in small-animal orthopedic surgery. Compared with Merck and Elanco, DePuy Synthes Vet has a more specialized focus on surgical and orthopedic applications rather than livestock production implants. The broader market remains fragmented, with specialized manufacturers competing across orthopedic, cardiovascular, urinary, therapeutic, and monitoring implant applications based on product breadth, clinical specialization, technology capabilities, and veterinary customer relationships.

Related Reports:

Veterinary Implants Devices Market by Type (Orthopedic, Cardiovascular, Active Electronic, Drug Delivery), Application (Health Monitoring, Treatment Management), Animal (Companion, Livestock, Performance), End User (Hospitals) - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]